Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001144204-17-034053
Filing Date
2017-06-26
Accepted
2017-06-26 16:15:38
Documents
4
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A v468942_10ka.htm 10-K/A 112249
2 EXHIBIT 10.31 v468942_ex10-31.htm EX-10.31 302425
3 EXHIBIT 31.7 v468942_ex31-7.htm EX-31.7 3965
4 EXHIBIT 31.8 v468942_ex31-8.htm EX-31.8 3968
  Complete submission text file 0001144204-17-034053.txt   423710
Mailing Address 9380 JUDICIAL DRIVE SAN DIEGO CA 92121
Business Address 9380 JUDICIAL DRIVE SAN DIEGO CA 92121 858-210-3700
Sorrento Therapeutics, Inc. (Filer) CIK: 0000850261 (see all company filings)

EIN.: 330344842 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-36150 | Film No.: 17930032
SIC: 8731 Services-Commercial Physical & Biological Research